Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out the advertisement of prescriptions for injectable weight-loss drugs without ...

On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform. This latest release introduces advanced ...

Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...

As previously disclosed, UHP submitted to the FDA an Investigational Device Exemption application (IDE) last November, the approval of which is a precondition to enroll patients in the planned study.

The US medicines regulator approved a new type of ... US into an opioid epidemic more than two decades ago. The Food and Drug Administration (FDA) said it approved Vertex Pharmaceuticals' Journavx ...

There is 'definitely a public interest' in Americans knowing if Prince Harry told the truth about his drug taking when he applied for a US visa, according to a royal expert. The Daily Mail's Diary ...

It's drug and alcohol deaths, but it's also car collisions, it's circulatory and metabolic diseases — causes that are very different from each other. That tells us this isn't one simple problem ...

A decades-old U.S. government ban on federally licensed firearms dealers selling handguns to adults under the age of 21 is unconstitutional, a U.S. appeals court held on Thursday, citing recent U ...

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with certain patient monitors from Contec and Epsimed and urged ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...